Several mutations in tumor-suppressor genes, including P53, adenomatous polyposis coli (APC), E-cadherin and RUNX3 [3], [5], as well as in oncogenes like k-ras, HER2 and β-catenin [3], [6], [7], have been documented in GC. This evidence concerns the gene APC and gastric cancer.